Exact Mass: 318.0536884

Exact Mass Matches: 318.0536884

Found 41 metabolites which its exact mass value is equals to given mass value 318.0536884, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

DMPP

1,1-Dimethyl-4-phenylpiperazin-1-ium iodide

C12H19IN2 (318.0592924)

D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D005731 - Ganglionic Stimulants D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists

Clotiazepam

5-(2-chlorophenyl)-7-ethyl-1-methyl-1H,2H,3H-thieno[2,3-e][1,4]diazepin-2-one

C16H15ClN2OS (318.05935700000003)

Clotiazepam is only found in individuals that have used or taken this drug. It is a benzodiazepine derivative, not approved for sale in the U.S. or Canada, but has been approved in the U.K. It is a schedule IV drug in Canada.Clotiazepam acts at the benzodiazepine receptors (BZD). This agonizes the action of GABA, increasing the frequency of opening of the channel chlorinates and penetration of the ions chlorinates through the ionophore. Increase in membrane polarization decreases the probability of discharge of neurons. N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

ZINC91581

C15H12Cl2N4 (318.0438972)

Methyl 4-cyano-5-(tetrahydro-1H-pyrrol-1-yl)-3-(2-thienyl)thiophene-2-carboxylate

C15H14N2O2S2 (318.04966640000004)

2-Dichloro-acetamido-3-(p-acetamidophenyl)-propan-1-ol

C13H16Cl2N2O3 (318.05379259999995)

6-Sulfo-chinovose-glycerin|6-Sulfo-chinovose-glycerol|6-Sulfo-O-alpha-D-chinopyranosyl-(1->1)-glycerin|6-Sulfo-O-alpha-quino-pyranosyl-(1->1)-glycerin

C9H18O10S (318.06206480000003)

clotiazepam

5-(2-chlorophenyl)-7-ethyl-1-methyl-1H,2H,3H-thieno[2,3-e][1,4]diazepin-2-one

C16H15ClN2OS (318.05935700000003)

N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

Vincofos

2,2-dichloroethenyl methyl octyl phosphate

C11H21Cl2O4P (318.05544560000004)

C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

3,5-bis(trifluoromethyl)benzophenone

C15H8F6O (318.04793099999995)

(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)methyl4-methylbenzene sulfonate

C13H18O5S2 (318.0595618)

Propylphosphonic anhydride

C9H21O6P3 (318.0550956)

2,2-thiophene-2,5-diylbis(benzoxazole)

C18H10N2O2S (318.04629600000004)

3,4-di(trifluoromethyl)benzophenone

C15H8F6O (318.04793099999995)

5-BROMO-3-(2-PHENYL-PYRROLIDIN-1-YL)-PYRAZIN-2-YLAMINE

C14H15BrN4 (318.048001)

4-(4-CHLORO-7-(METHYLSULFONYL)-6,7-DIHYDRO-5H-PYRROLO[2,3-D]PYRIMIDIN-2-YL)MORPHOLINE

C11H15ClN4O3S (318.055335)

3,3-bis(trifluoromethyl)benzophenone

C15H8F6O (318.04793099999995)

4-[3,5-bis(trifluoromethyl)phenyl]benzaldehyde

C15H8F6O (318.04793099999995)

2-CHLORO-N-[4-(MORPHOLINE-4-SULFONYL)-PHENYL]-ACETAMIDE

C12H15ClN2O4S (318.044102)

2-Methyl-2-propanyl 3-bromo-1-oxa-2,8-diazaspiro[4.5]dec-2-ene-8- carboxylate

C12H19BrN2O3 (318.0578964)

1-[2-(Z)-Methoxyimino-2-(2-aminothiazol-4-yl)acetyl]benzotrizole-3-oxide

C12H10N6O3S (318.0535070000001)

Optical brightening agent EBF C.I. No:185

C18H10N2O2S (318.04629600000004)

praseodymium(iii) isopropoxide

C9H21O3Pr (318.0567186)

Disulfide,1,2-di-2-naphthalenyl

C20H14S2 (318.0536884)

Flutemazepam

C16H12ClFN2O2 (318.05712939999995)

C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

2-Chloro-1-[3-(4-methylphenyl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]ethanone

C16H15ClN2OS (318.05935700000003)

N-{1-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-1H-1,2,4-triazol-3-yl}-N,N-dimethyliminoformamide

C11H10ClF3N6 (318.0607526)

Benzo(1,2-b:4,5-b)bis(1)benzothiophene, 6,12-dimethyl-

C20H14S2 (318.0536884)

1-[(2-Amino-4-chloro-5-methylphenyl)sulfonyl]-L-proline

C12H15ClN2O4S (318.044102)

4-methylphenyl 5-phospho-alpha-D-ribofuranoside

C12H15O8P-2 (318.050452)

[(2S,3S,4S,5R,6S)-6-[(2S)-2,3-dihydroxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C9H18O10S (318.06206480000003)

N-(5-phosphonatopyridoxyl)-D-alaninate(2-)

C11H15N2O7P-2 (318.061685)

N-(5-phosphonatopyridoxyl)-L-alaninate(2-)

C11H15N2O7P-2 (318.061685)

2-fluoro-N-(8-hydroxy-5-quinolinyl)benzenesulfonamide

C15H11FN2O3S (318.0474388)

[(2S,3S,4S,5R,6S)-6-[(2R)-2,3-bis(oxidanyl)propoxy]-3,4,5-tris(oxidanyl)oxan-2-yl]methanesulfonic acid

C9H18O10S (318.06206480000003)

1,1-Dimethyl-4-phenylpiperazinium iodide

1,1-Dimethyl-4-phenylpiperazin-1-ium iodide

C12H19IN2 (318.0592924)

N-(5-phosphonatopyridoxyl)-D-alaninate(2-)

C11H15N2O7P (318.061685)

Dianion of N-(5-phosphopyridoxyl)-D-alanine having anionic carboxy, hydroxy and phosphate groups and the secondary amino group and pyridine nitrogen protonated.

N-(5-phosphonatopyridoxyl)-L-alaninate(2-)

C11H15N2O7P (318.061685)

An organophosphate oxoanion that is the dianion of N-(5-phosphopyridoxyl)-L-alanine having anionic carboxy, hydroxy and phosphate groups with the secondary amino group and pyridine nitrogen protonated.